These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2720301)

  • 1. Tolerance to cromakalim in the rat uterus in vivo.
    Downing SJ; Miller M; Hollingsworth M
    Br J Pharmacol; 1989 Mar; 96(3):732-8. PubMed ID: 2720301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One way cross tolerance between cromakalim and salbutamol in the uterus of the rat in vivo.
    Downing SJ; Hollingsworth M
    Br J Pharmacol; 1992 Jan; 105(1):129-34. PubMed ID: 1317733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ovarian steroids on myometrial sensitivity and tolerance to relaxin in the rat in vivo: lack of cross-tolerance between relaxin, salbutamol and cromakalim.
    Downing SJ; Hollingsworth M
    J Endocrinol; 1992 Oct; 135(1):17-28. PubMed ID: 1431679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross tolerance between cromakalim and RP49356 in the uterus of the rat in vivo and in vitro.
    Piper I; Downing SJ; Hollingsworth M
    Eur J Pharmacol; 1992 Sep; 219(3):347-53. PubMed ID: 1425963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the haemodynamic profiles of Ro 31-6930, cromakalim and nifedipine in anaesthetised normotensive rats.
    Duty S; Paciorek PM; Waterfall JF; Weston AH
    Eur J Pharmacol; 1990 Aug; 185(1):35-42. PubMed ID: 2226633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of cromakalim (BRL 34915) in healthy volunteers.
    Fox JS; Whitehead EM; Shanks RG
    Br J Clin Pharmacol; 1991 Jul; 32(1):45-9. PubMed ID: 1888641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antihypertensive property of NIP-121, a novel potassium channel opener in rats.
    Masuda Y; Arakawa C; Yokoyama T; Shigenobu K; Tanaka S
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):190-7. PubMed ID: 1717778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
    D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
    Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
    Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
    Cavero I; Mondot S; Mestre M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
    Pratz J; Mondot S; Montier F; Cavero I
    J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between myometrial relaxants and oxytocin: a comparison between relaxin, cromakalim and salbutamol.
    Downing SJ; Hollingsworth M
    J Endocrinol; 1992 Oct; 135(1):29-36. PubMed ID: 1431680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of K+ channels in the relaxant responses to various agonists in estrogen primed rat uterus.
    Mehta AA; Dave KC; Goyal RK
    Indian J Physiol Pharmacol; 1995 Apr; 39(2):140-4. PubMed ID: 7649602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
    J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies with the potassium channel activator cromakalim in normotensive and hypertensive subjects.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):790-5. PubMed ID: 1703602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim.
    Newgreen DT; Bray KM; McHarg AD; Weston AH; Duty S; Brown BS; Kay PB; Edwards G; Longmore J; Southerton JS
    Br J Pharmacol; 1990 Jul; 100(3):605-13. PubMed ID: 2167738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.